Perioperative management of lithium in the patient undergoing pituitary surgery: a case report.
Emma RichardsMiran PankhaniaCharlotte ThomasKaran JollyJohn AyukShahzada AhmedPublished in: British journal of neurosurgery (2022)
Lithium is a psychotropic drug used primarily in the treatment of bipolar disorder. It is renally excreted and characteristically causes nephrogenic diabetes insipidus as an adverse drug reaction. Lithium also requires serum level monitoring as there is a narrow therapeutic window and untreated toxicity can result in neurological sequelae including drowsiness, coma, seizures, and ultimately death. We present the case of a 65-year old man admitted for pituitary surgery complicated by post-operative difficult fluid management and subsequent lithium toxicity. We highlight this rare situation and the need to be vigilant in the peri-operative period with any patients on lithium who undergo pituitary surgery.
Keyphrases
- minimally invasive
- adverse drug
- coronary artery bypass
- solid state
- bipolar disorder
- end stage renal disease
- surgical site infection
- type diabetes
- oxidative stress
- cardiovascular disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- growth hormone
- patients undergoing
- prognostic factors
- major depressive disorder
- case report
- percutaneous coronary intervention
- patient reported outcomes
- acute coronary syndrome
- adipose tissue
- smoking cessation